Rifaximin for sickle cell disease

被引：18

作者：

Lim, Seah H. ^{[1
,2
]}

Dutta, Dibyendu ^{[1
,2
]}

Moore, Judy ^{[2
]}

机构：

[1] New York Med Coll, Dept Med, Div Hematol & Hemostasis, Valhalla, NY 10595 USA

[2] Westchester Med Ctr, Canc Inst, 19 Bradhurst Ave,Suite 2575S, Hawthorne, NY 10532 USA

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2019年 / 94卷 / 12期

关键词：

D O I：

10.1002/ajh.25637

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E325 / E328

页数：4

共 14 条

[1] Rifaximin Treatment in Hepatic Encephalopathy [J].

Bass, Nathan M. ;

Mullen, Kevin D. ;

Sanyal, Arun ;

Poordad, Fred ;

Neff, Guy ;

Leevy, Carroll B. ;

Sigal, Samuel ;

Sheikh, Muhammad Y. ;

Beavers, Kimberly ;

Frederick, Todd ;

Teperman, Lewis ;

Hillebrand, Donald ;

Huang, Shirley ;

Merchant, Kunal ;

Shaw, Audrey ;

Bortey, Enoch ;

Forbes, William P. .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (12) :1071-1081

[2] THE ACUTE CHEST SYNDROME IN SICKLE-CELL DISEASE - INCIDENCE AND RISK-FACTORS [J].

CASTRO, O ;

BRAMBILLA, DJ ;

THORINGTON, B ;

REINDORF, CA ;

SCOTT, RB ;

GILLETTE, P ;

VERA, JC ;

LEVY, PS ;

JOHNSON, R ;

MCMAHON, L ;

PLATT, O ;

OHENEFREMPONG, K ;

GILL, F ;

VICHINSKY, E ;

LUBIN, B ;

BRAY, G ;

KELLEHER, JF ;

LEIKEN, S ;

BANK, A ;

PIOMELLI, S ;

ROSSE, WF ;

KINNEY, TR ;

LESSIN, L ;

SMITH, J ;

KHAKOO, Y ;

DOSIK, H ;

DIAMOND, S ;

BELLEVUE, R ;

WANG, W ;

WILIMAS, J ;

MILNER, P ;

BROWN, A ;

MILLER, S ;

RIEDER, R ;

LANDE, W ;

EMBURY, S ;

MENTZER, W ;

WETHERS, D ;

GROVER, R ;

KOSHY, M ;

TALISHY, N ;

PEGELOW, C ;

KLUG, P ;

STEINBERG, M ;

KRAUS, A ;

ZARKOWSKY, H ;

DAMPIER, C ;

PEARSON, H ;

RITCHEY, K ;

LEVY, P .

BLOOD, 1994, 84 (02) :643-649

[3] Rifaximin: An Antibiotic with Important Biologic Effects [J].

DuPont, H. L. .

MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2016, 16 (03) :200-205

[4] Intestinal injury and gut permeability in sickle cell disease [J].

Dutta, Dibyendu ;

Methe, Barbara ;

Amar, Salomon ;

Morris, Alison ;

Lim, Seah H. .

JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17 (1)

[5] Effects of rifaximin on circulating aged neutrophils in sickle cell disease [J].

Dutta, Dibyendu ;

Methe, Barbara A. ;

Morris, Alison ;

Lim, Seah H. .

AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (06) :E175-E176

[6] Silent cerebral infarcts in sickle cell anemia: A risk factor analysis [J].

Kinney, TR ;

Sleeper, LA ;

Wang, WC ;

Zimmerman, RA ;

Pegelow, CH ;

Ohene-Frempong, K ;

Wethers, DL ;

Bello, JA ;

Vichinsky, EP ;

Moser, FG ;

Gallagher, DM ;

DeBaun, MR ;

Platt, OS ;

Miller, ST .

PEDIATRICS, 1999, 103 (03) :640-645

[7] Applicability of and potential barriers preventing allogeneic stem cell transplant in sickle cell patients treated outside a sickle cell program [J].

Kumar, Arun ;

Ahmed, Jibran ;

Anwar, Asad ;

Fanucchi, Michael ;

Lim, Seah H. .

AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (06) :E150-E152

[8] Neutrophil activation in sickle cell disease [J].

Lard, LR ;

Mul, FPJ ;

de Haas, M ;

Roos, D ;

Duits, AJ .

JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 66 (03) :411-415

[9] Intestinal microbiome analysis revealed dysbiosis in sickle cell disease [J].

Lim, Seah H. ;

Morris, Alison ;

Li, Kelvin ;

Fitch, Adam C. ;

Fast, Loren ;

Goldberg, Laura ;

Quesenberry, Matthew ;

Sprinz, Philippa ;

Methe, Barbara .

AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (04) :E91-E93

[10] Sickle cell vaso-occlusive crisis: it's a gut feeling [J].

Lim, Seah H. ;

Fast, Loren ;

Morris, Alison .

JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14

← 1 2 →